Iron deficiency is the most common cause of hyporesponsiveness to erythropoietin, and guidelines recommend intravenous rather than oral iron replacement among hemodialysis patients who require iron.
If you want to change selection, open document below and click on "Move attachment"
pdf
owner:
ELBOMBARDO - (no access) - MKSAP_17.pdf, p3612
Summary
| status | not read | | reprioritisations | |
|---|
| last reprioritisation on | | | suggested re-reading day | |
|---|
| started reading on | | | finished reading on | |
|---|
Details